Shiv Kumar Bhardwaj
Shiv Kumar Bhardwaj has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Abhisek Satapathy
Pt J.N.M. Medical College, Railway Station Rd, Moudhapara, Raipur, 492001, C.G., India
8 shared publications - Abinash Satapathy
College of Veterinary Science and Animal Husbandry, Anjora, Durg, 491001, C.G, India
8 shared publications - Kunal Chandrakar
University College of Pharmacy, CSVTU, Bhilai- 491107, C.G., India
6 shared publications - Poonam Sahu
Department of Pharmacology, Columbia Institute of Pharmacy, Raipur, India
6 shared publications - Trilochan Satapathy
Columbia Institute of Pharmacy, Raipur, 493111, Chhattisgarh, India
6 shared publications Dharmendra Sahu
Gracious College of Pharmacy, Village-Belbhata, Abhanpur, Raipur-493661, Chhattisgarh, India
5 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (10) , 129-140
A Review on the Synthesis, Characterization and Evaluation of Benzimidazole Derivatives for Antimicrobial and Antioxidant Activities
Benzimidazole is a privileged nitrogen-containing fused heterocyclic scaffold that has attracted considerable interest in medicinal and pharmaceutical chemistry because of its structural versatility, favorable physicochemical properties and broad biological profile. The benzimidazole nucleus comprises a benzene ring fused with an imidazole ring containing two nitrogen atoms, providing multiple sites for structural modification and interaction with biological targets. This review summarizes recent advances in the synthesis, characterization, antimicrobial evaluation and antioxidant potential of benzimidazole derivatives, with particular emphasis on structure-activity relationships (SAR). Classical synthetic approaches mainly involve the condensation of o-phenylenediamine with aldehydes, carboxylic acids and related carbonyl compounds, whereas modern methodologies increasingly employ microwave irradiation, solvent-free conditions, recyclable catalysts, nano-catalysts, photocatalysis, mechanochemistry and other green-chemistry strategies. Structural characterization is commonly performed using Fourier-transform infrared spectroscopy (FTIR), ^1H and ^13C nuclear magnetic resonance (NMR), mass spectrometry, elemental analysis, ultraviolet-visible spectroscopy and, where appropriate, single-crystal X-ray diffraction. Benzimidazole derivatives demonstrate promising antibacterial and antifungal activities against diverse pathogens. Their antioxidant potential is commonly evaluated using DPPH, ABTS, FRAP and lipid-peroxidation assays. Overall, benzimidazole provides a versatile platform for developing multifunctional antimicrobial and antioxidant agents, although standardized biological protocols, mechanistic validation, selectivity assessment, pharmacokinetic studies and in vivo investigations remain necessary for successful therapeutic translation. Keywords: Benzimidazole; Heterocyclic chemistry; Antimicrobial activity; Antioxidant activity; Structure-activity relationship
- 15 October 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (10) , 129-140
Open AccessA Review on the Synthesis, Characterization and Evaluation of Benzimidazole Derivatives for Antimicrobial and Antioxidant Activities
Benzimidazole is a privileged nitrogen-containing fused heterocyclic scaffold that has attracted considerable interest in medicinal and pharmaceutical chemistry because of its structural versatility, favorable physicochemical properties and broad biological profile. The benzimidazole nucleus comprises a benzene ring fused with an imidazole ring containing two nitrogen atoms, providing multiple sites for structural modification and interaction with biological targets. This review summarizes recent advances in the synthesis, characterization, antimicrobial evaluation and antioxidant potential of benzimidazole derivatives, with particular emphasis on structure-activity relationships (SAR). Classical synthetic approaches mainly involve the condensation of o-phenylenediamine with aldehydes, carboxylic acids and related carbonyl compounds, whereas modern methodologies increasingly employ microwave irradiation, solvent-free conditions, recyclable catalysts, nano-catalysts, photocatalysis, mechanochemistry and other green-chemistry strategies. Structural characterization is commonly performed using Fourier-transform infrared spectroscopy (FTIR), ^1H and ^13C nuclear magnetic resonance (NMR), mass spectrometry, elemental analysis, ultraviolet-visible spectroscopy and, where appropriate, single-crystal X-ray diffraction. Benzimidazole derivatives demonstrate promising antibacterial and antifungal activities against diverse pathogens. Their antioxidant potential is commonly evaluated using DPPH, ABTS, FRAP and lipid-peroxidation assays. Overall, benzimidazole provides a versatile platform for developing multifunctional antimicrobial and antioxidant agents, although standardized biological protocols, mechanistic validation, selectivity assessment, pharmacokinetic studies and in vivo investigations remain necessary for successful therapeutic translation. Keywords: Benzimidazole; Heterocyclic chemistry; Antimicrobial activity; Antioxidant activity; Structure-activity relationship
- Open Access
- 15 October 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (10) , 165-178
Formulation and Evaluation of Floating Oral In-Situ Gel of Etodolac: A Comprehensive Review
Etodolac is a non-steroidal anti-inflammatory drug (NSAID) used for the management of pain and inflammatory disorders. Although conventional oral administration provides effective systemic exposure, the relatively short terminal half-life and rapid gastrointestinal transit may necessitate repeated administration and may produce fluctuating drug concentrations. Gastroretective drug delivery systems (GRDDS), particularly floating oral in-situ gels, provide an attractive approach for prolonging gastric residence and regulating drug release. This review and experimental framework focus on the development of a floating oral in-situ gel of etodolac using suitable hydrophilic and ion-responsive polymers. The formulation is designed to remain in the stomach by generating a low-density, gelled structure following contact with gastric fluid. Sodium alginate, gellan gum, hydroxypropyl methylcellulose (HPMC) and suitable gas-generating agents can be investigated to achieve rapid gelation, adequate floating ability, appropriate viscosity and sustained drug release. Important formulation and evaluation parameters include appearance, pH, viscosity, gelation characteristics, floating lag time, total floating duration, drug content, swelling, in-vitro dissolution, release kinetics and stability. Optimization of polymer concentration and polymer combinations is essential because viscosity, gel strength, buoyancy and drug diffusion are interdependent. A well-designed etodolac floating in-situ gel may provide prolonged gastric residence and controlled drug delivery, although in-vivo gastric-retention and pharmacokinetic studies are required to establish its clinical advantage. Keywords: Etodolac; Floating in-situ gel; Gastroretective drug delivery; Sodium alginate; Sustained release
- 15 October 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (10) , 165-178
Open AccessFormulation and Evaluation of Floating Oral In-Situ Gel of Etodolac: A Comprehensive Review
Etodolac is a non-steroidal anti-inflammatory drug (NSAID) used for the management of pain and inflammatory disorders. Although conventional oral administration provides effective systemic exposure, the relatively short terminal half-life and rapid gastrointestinal transit may necessitate repeated administration and may produce fluctuating drug concentrations. Gastroretective drug delivery systems (GRDDS), particularly floating oral in-situ gels, provide an attractive approach for prolonging gastric residence and regulating drug release. This review and experimental framework focus on the development of a floating oral in-situ gel of etodolac using suitable hydrophilic and ion-responsive polymers. The formulation is designed to remain in the stomach by generating a low-density, gelled structure following contact with gastric fluid. Sodium alginate, gellan gum, hydroxypropyl methylcellulose (HPMC) and suitable gas-generating agents can be investigated to achieve rapid gelation, adequate floating ability, appropriate viscosity and sustained drug release. Important formulation and evaluation parameters include appearance, pH, viscosity, gelation characteristics, floating lag time, total floating duration, drug content, swelling, in-vitro dissolution, release kinetics and stability. Optimization of polymer concentration and polymer combinations is essential because viscosity, gel strength, buoyancy and drug diffusion are interdependent. A well-designed etodolac floating in-situ gel may provide prolonged gastric residence and controlled drug delivery, although in-vivo gastric-retention and pharmacokinetic studies are required to establish its clinical advantage. Keywords: Etodolac; Floating in-situ gel; Gastroretective drug delivery; Sodium alginate; Sustained release
- Open Access
- 15 September 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (9) , 326-334
Impact of Nasal Delivery Devices on Olfactory Drug Deposition
Nasal delivery offers a promising non-invasive approach for targeting therapeutics to the brain through the olfactory region. However, conventional nasal administration frequently produces predominant deposition in the anterior nasal cavity, limiting drug access to the olfactory epithelium. Nasal delivery devices play a critical role in overcoming these anatomical and aerodynamic barriers by controlling spray velocity, droplet or particle size, plume geometry, airflow, dose volume and administration direction. This review examines the impact of conventional and advanced nasal delivery devices on olfactory drug deposition, with particular emphasis on metered-dose sprays, nasal drops, nebulizers, powder devices, atomizers, breath-powered bidirectional systems and specialized nose-to-brain platforms. The influence of device design and administration parameters on regional deposition, mucosal retention and potential nose-to-brain transport is discussed. Computational fluid dynamics, nasal cast models, imaging techniques and experimental approaches used for deposition assessment are also reviewed. Emerging personalized and digitally optimized devices may provide improved and reproducible olfactory targeting for future CNS therapeutics. Keywords: Olfactory deposition, nasal delivery devices, nose-to-brain delivery, intranasal drug delivery, olfactory targeting
- 15 September 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (9) , 326-334
Open AccessImpact of Nasal Delivery Devices on Olfactory Drug Deposition
Nasal delivery offers a promising non-invasive approach for targeting therapeutics to the brain through the olfactory region. However, conventional nasal administration frequently produces predominant deposition in the anterior nasal cavity, limiting drug access to the olfactory epithelium. Nasal delivery devices play a critical role in overcoming these anatomical and aerodynamic barriers by controlling spray velocity, droplet or particle size, plume geometry, airflow, dose volume and administration direction. This review examines the impact of conventional and advanced nasal delivery devices on olfactory drug deposition, with particular emphasis on metered-dose sprays, nasal drops, nebulizers, powder devices, atomizers, breath-powered bidirectional systems and specialized nose-to-brain platforms. The influence of device design and administration parameters on regional deposition, mucosal retention and potential nose-to-brain transport is discussed. Computational fluid dynamics, nasal cast models, imaging techniques and experimental approaches used for deposition assessment are also reviewed. Emerging personalized and digitally optimized devices may provide improved and reproducible olfactory targeting for future CNS therapeutics. Keywords: Olfactory deposition, nasal delivery devices, nose-to-brain delivery, intranasal drug delivery, olfactory targeting
- Open Access
- 15 September 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (9) , 237-251
Formulation, Evaluation and Optimization of Metformin Hydrochloride 500 mg Sustained-Release Tablets Using a Quality-By-Design Approach: A Comprehensive Review
Metformin hydrochloride is a first-line oral antihyperglycemic agent widely used for the management of type 2 diabetes mellitus. Despite its therapeutic effectiveness, its high aqueous solubility, relatively limited membrane permeability, dose-related gastrointestinal effects and restricted intestinal absorption window can complicate the development of prolonged-release oral formulations. Sustained-release (SR) matrix tablets provide a rational strategy for controlling drug release, reducing dosing frequency, improving dosing convenience and maintaining more consistent systemic exposure. This review presents a Quality-by-Design (QbD)-oriented framework for the formulation, evaluation and optimization of 500-mg metformin hydrochloride SR matrix tablets. The framework incorporates the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), Critical Material Attributes (CMAs), Critical Process Parameters (CPPs), risk assessment, Design of Experiments (DoE), formulation optimization and lifecycle control. Particular emphasis is placed on hydrophilic matrix systems containing hydroxypropyl methylcellulose (HPMC), together with the roles of hydrophobic and natural polymers and functional excipients. Key formulation and process variables, including polymer concentration, viscosity grade, drug-to-polymer ratio, compression force, porosity and manufacturing conditions, are considered in relation to matrix hydration, gel formation, diffusion, erosion and drug-release behavior. Evaluation includes pre-formulation, powder properties, tablet quality, assay, content uniformity, compatibility, swelling, dissolution, release kinetics and stability. Emerging tools such as process analytical technology, physiologically based biopharmaceutic modeling, artificial intelligence, machine learning and continuous manufacturing may further enhance predictive development, robustness, scalability, and lifecycle control of metformin SR tablets. Keywords: Metformin Hydrochloride; Sustained-Release Tablets; Quality By Design; Design Of Experiments; Matrix Tablets.
- 15 September 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (9) , 237-251
Open AccessFormulation, Evaluation and Optimization of Metformin Hydrochloride 500 mg Sustained-Release Tablets Using a Quality-By-Design Approach: A Comprehensive Review
Metformin hydrochloride is a first-line oral antihyperglycemic agent widely used for the management of type 2 diabetes mellitus. Despite its therapeutic effectiveness, its high aqueous solubility, relatively limited membrane permeability, dose-related gastrointestinal effects and restricted intestinal absorption window can complicate the development of prolonged-release oral formulations. Sustained-release (SR) matrix tablets provide a rational strategy for controlling drug release, reducing dosing frequency, improving dosing convenience and maintaining more consistent systemic exposure. This review presents a Quality-by-Design (QbD)-oriented framework for the formulation, evaluation and optimization of 500-mg metformin hydrochloride SR matrix tablets. The framework incorporates the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), Critical Material Attributes (CMAs), Critical Process Parameters (CPPs), risk assessment, Design of Experiments (DoE), formulation optimization and lifecycle control. Particular emphasis is placed on hydrophilic matrix systems containing hydroxypropyl methylcellulose (HPMC), together with the roles of hydrophobic and natural polymers and functional excipients. Key formulation and process variables, including polymer concentration, viscosity grade, drug-to-polymer ratio, compression force, porosity and manufacturing conditions, are considered in relation to matrix hydration, gel formation, diffusion, erosion and drug-release behavior. Evaluation includes pre-formulation, powder properties, tablet quality, assay, content uniformity, compatibility, swelling, dissolution, release kinetics and stability. Emerging tools such as process analytical technology, physiologically based biopharmaceutic modeling, artificial intelligence, machine learning and continuous manufacturing may further enhance predictive development, robustness, scalability, and lifecycle control of metformin SR tablets. Keywords: Metformin Hydrochloride; Sustained-Release Tablets; Quality By Design; Design Of Experiments; Matrix Tablets.
- Open Access
- 15 September 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (9) , 157-174
Formulation and Evaluation of Niosome-Based Isotretinoin Gel: A Comprehensive Review
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit affecting millions of adolescents and adults worldwide. Although isotretinoin remains one of the most effective retinoids for acne management, its conventional topical formulations are associated with poor aqueous solubility, limited skin penetration, photo-instability, irritation, erythema, and reduced patient compliance. Nano-vesicular drug delivery systems have emerged as promising alternatives to overcome these limitations. Among them, niosomes have attracted considerable attention owing to their excellent biocompatibility, chemical stability, ease of preparation, cost-effectiveness and ability to encapsulate both hydrophilic and lipophilic therapeutic agents. Incorporation of isotretinoin into niosomal vesicles followed by dispersion in a topical gel provides controlled drug release, enhanced skin retention, improved follicular targeting, reduced systemic absorption and minimized local adverse effects while maintaining therapeutic efficacy. This review comprehensively discusses the pharmaceutical aspects of isotretinoin-loaded niosomal gels, including formulation strategies, selection of surfactants and membrane stabilizers, methods of niosome preparation, vesicle characterization, gel formulation approaches, physicochemical evaluation, stability assessment and biological performance. Furthermore, recent advances in vesicular nanocarriers, quality-by-design approaches, optimization techniques and translational perspectives are highlighted. Current challenges related to large-scale manufacturing, regulatory considerations and clinical translation are also discussed. Overall, niosomal gel represents a promising topical delivery platform capable of improving the therapeutic performance of isotretinoin and may contribute to safer, more effective and patient-friendly acne treatment. Keywords: Isotretinoin, niosomes, topical gel, vesicular drug delivery, acne vulgaris
- 15 September 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (9) , 157-174
Open AccessFormulation and Evaluation of Niosome-Based Isotretinoin Gel: A Comprehensive Review
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit affecting millions of adolescents and adults worldwide. Although isotretinoin remains one of the most effective retinoids for acne management, its conventional topical formulations are associated with poor aqueous solubility, limited skin penetration, photo-instability, irritation, erythema, and reduced patient compliance. Nano-vesicular drug delivery systems have emerged as promising alternatives to overcome these limitations. Among them, niosomes have attracted considerable attention owing to their excellent biocompatibility, chemical stability, ease of preparation, cost-effectiveness and ability to encapsulate both hydrophilic and lipophilic therapeutic agents. Incorporation of isotretinoin into niosomal vesicles followed by dispersion in a topical gel provides controlled drug release, enhanced skin retention, improved follicular targeting, reduced systemic absorption and minimized local adverse effects while maintaining therapeutic efficacy. This review comprehensively discusses the pharmaceutical aspects of isotretinoin-loaded niosomal gels, including formulation strategies, selection of surfactants and membrane stabilizers, methods of niosome preparation, vesicle characterization, gel formulation approaches, physicochemical evaluation, stability assessment and biological performance. Furthermore, recent advances in vesicular nanocarriers, quality-by-design approaches, optimization techniques and translational perspectives are highlighted. Current challenges related to large-scale manufacturing, regulatory considerations and clinical translation are also discussed. Overall, niosomal gel represents a promising topical delivery platform capable of improving the therapeutic performance of isotretinoin and may contribute to safer, more effective and patient-friendly acne treatment. Keywords: Isotretinoin, niosomes, topical gel, vesicular drug delivery, acne vulgaris
- Open Access
- 16 August 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (8) , 217-222
Neuroprotective Activity of Medicinal Plants: Comprehensive Review of Phytochemicals, Neuronal Survival Mechanisms, Pharmacological Evidence, Safety Evaluation, Clinical Potential
Neurodegenerative disorders and neuronal injuries resulting from oxidative stress, inflammation, excitotoxicity and mitochondrial dysfunction represent significant global health challenges. Medicinal plants possessing neuroprotective properties are increasingly investigated as potential therapeutic agents for prevention and management of neurological diseases. This systematic review evaluates phytochemicals responsible for neuroprotection, mechanisms underlying neuronal survival including antioxidant defense, modulation of neurotransmission, inhibition of apoptosis and regulation of neuroinflammatory pathways, along with pharmacological evidence and safety considerations. Flavonoids, alkaloids, terpenoids, phenolic acids and glycosides contribute to preservation of neuronal integrity and synaptic function. Experimental studies demonstrate improvement in cognitive performance and reduction in neuronal degeneration. Although clinical data remain limited, plant-derived neuroprotective compounds show promising therapeutic potential requiring further standardization and controlled clinical evaluation. Keywords: Neuroprotection; Medicinal plants; Neuronal survival; Oxidative stress; Phytochemicals.
- 16 August 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (8) , 217-222
Open AccessNeuroprotective Activity of Medicinal Plants: Comprehensive Review of Phytochemicals, Neuronal Survival Mechanisms, Pharmacological Evidence, Safety Evaluation, Clinical Potential
Neurodegenerative disorders and neuronal injuries resulting from oxidative stress, inflammation, excitotoxicity and mitochondrial dysfunction represent significant global health challenges. Medicinal plants possessing neuroprotective properties are increasingly investigated as potential therapeutic agents for prevention and management of neurological diseases. This systematic review evaluates phytochemicals responsible for neuroprotection, mechanisms underlying neuronal survival including antioxidant defense, modulation of neurotransmission, inhibition of apoptosis and regulation of neuroinflammatory pathways, along with pharmacological evidence and safety considerations. Flavonoids, alkaloids, terpenoids, phenolic acids and glycosides contribute to preservation of neuronal integrity and synaptic function. Experimental studies demonstrate improvement in cognitive performance and reduction in neuronal degeneration. Although clinical data remain limited, plant-derived neuroprotective compounds show promising therapeutic potential requiring further standardization and controlled clinical evaluation. Keywords: Neuroprotection; Medicinal plants; Neuronal survival; Oxidative stress; Phytochemicals.
- Open Access
- 15 March 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (3) , 328-355
RNAi-Loaded Nanocarriers Targeting the IL-6/JAK-STAT3-NF-κB Cytokine Axis in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent synovial inflammation, progressive cartilage degradation, and bone erosion driven by complex cytokine-mediated signaling networks. Central to its pathogenesis is the dysregulated interplay of the interleukin-6 (IL-6)/Janus kinase (JAK)-signal transducer and activator of transcription-3 (STAT3) and nuclear factor kappa-B (NF-κB) pathways, which coordinate transcription of pro-inflammatory cytokines, angiogenic mediators, and osteoclastogenic factors. Conventional therapeutic strategies, including biologics and small-molecule inhibitors, primarily target extracellular mediators and often fail to adequately suppress intracellular signaling redundancy, leading to incomplete or transient clinical responses. RNA interference (RNAi) has emerged as a promising gene-silencing approach capable of selectively downregulating disease-driving transcripts at the post-transcriptional level. However, the clinical translation of RNAi is limited by instability, poor cellular uptake, and rapid degradation of naked small interfering RNA (siRNA). Nanocarrier-based delivery systems provide a transformative solution by protecting siRNA, enhancing pharmacokinetics, enabling targeted delivery to pathogenic cells, and facilitating cytoplasmic release through stimuli-responsive mechanisms. These RNAi-loaded nanoplatforms can simultaneously modulate multiple inflammatory nodes, reprogram immune-cell behavior, attenuate oxidative stress, and inhibit osteoclast genesis, thereby addressing RA as a systems-level disease. Furthermore, advances in precision targeting and multifunctional nanotechnology highlight the broader applicability of this strategy to other cytokine-driven disorders. Despite existing translational challenges, RNAi nanomedicine represents a paradigm shift toward network-oriented, gene-level therapeutics with the potential to achieve durable immunomodulation and disease modification in rheumatoid arthritis. Keywords: Inflammation; JAK-STAT3 signaling; nanocarriers; NF-κB; RNA interference; rheumatoid arthritis
- 15 March 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (3) , 328-355
Open AccessRNAi-Loaded Nanocarriers Targeting the IL-6/JAK-STAT3-NF-κB Cytokine Axis in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent synovial inflammation, progressive cartilage degradation, and bone erosion driven by complex cytokine-mediated signaling networks. Central to its pathogenesis is the dysregulated interplay of the interleukin-6 (IL-6)/Janus kinase (JAK)-signal transducer and activator of transcription-3 (STAT3) and nuclear factor kappa-B (NF-κB) pathways, which coordinate transcription of pro-inflammatory cytokines, angiogenic mediators, and osteoclastogenic factors. Conventional therapeutic strategies, including biologics and small-molecule inhibitors, primarily target extracellular mediators and often fail to adequately suppress intracellular signaling redundancy, leading to incomplete or transient clinical responses. RNA interference (RNAi) has emerged as a promising gene-silencing approach capable of selectively downregulating disease-driving transcripts at the post-transcriptional level. However, the clinical translation of RNAi is limited by instability, poor cellular uptake, and rapid degradation of naked small interfering RNA (siRNA). Nanocarrier-based delivery systems provide a transformative solution by protecting siRNA, enhancing pharmacokinetics, enabling targeted delivery to pathogenic cells, and facilitating cytoplasmic release through stimuli-responsive mechanisms. These RNAi-loaded nanoplatforms can simultaneously modulate multiple inflammatory nodes, reprogram immune-cell behavior, attenuate oxidative stress, and inhibit osteoclast genesis, thereby addressing RA as a systems-level disease. Furthermore, advances in precision targeting and multifunctional nanotechnology highlight the broader applicability of this strategy to other cytokine-driven disorders. Despite existing translational challenges, RNAi nanomedicine represents a paradigm shift toward network-oriented, gene-level therapeutics with the potential to achieve durable immunomodulation and disease modification in rheumatoid arthritis. Keywords: Inflammation; JAK-STAT3 signaling; nanocarriers; NF-κB; RNA interference; rheumatoid arthritis
- Open Access
- 15 March 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (3) , 268-288
Smart Nanocarrier Systems for Diabetic Wound Healing: Preclinical Innovations and Clinical Progress in Drug and Gene Delivery
Diabetic wounds represent a complex clinical challenge arising from the convergence of chronic inflammation, impaired angiogenesis, oxidative stress, neuropathy, infection, and dysregulated extracellular matrix remodeling. Conventional therapies targeting single pathological components have shown limited efficacy, underscoring the need for integrated and mechanistically informed treatment strategies. This review comprehensively examines nanocarrier-mediated drug delivery systems as a transformative platform for diabetic wound management, integrating herbal, synthetic, semi-synthetic and gene-based therapeutics across preclinical and clinical landscapes. Emphasis is placed on the molecular pathophysiology of diabetic wounds and how advanced nanocarrier platforms enable spatiotemporal control, enhanced bioavailability, and pathway-specific modulation of inflammatory, angiogenic, antimicrobial, and regenerative processes. Material-driven functionalities, including stimuli-responsive release and multifunctional hybrid systems are critically discussed in relation to disorder-specific wound phenotypes. Furthermore, the review evaluates current preclinical models, translational barriers and emerging clinical trends, highlighting the importance of patient stratification and precision wound nanomedicine. Collectively, this work positions nanocarrier-based therapeutics as a promising and adaptable approach capable of addressing the biological heterogeneity of diabetic wounds and advancing toward clinically meaningful outcomes. Keywords: angiogenesis; diabetic wounds; gene therapy; herbal therapeutics; nanocarriers; wound healing
- 15 March 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (3) , 268-288
Open AccessSmart Nanocarrier Systems for Diabetic Wound Healing: Preclinical Innovations and Clinical Progress in Drug and Gene Delivery
Diabetic wounds represent a complex clinical challenge arising from the convergence of chronic inflammation, impaired angiogenesis, oxidative stress, neuropathy, infection, and dysregulated extracellular matrix remodeling. Conventional therapies targeting single pathological components have shown limited efficacy, underscoring the need for integrated and mechanistically informed treatment strategies. This review comprehensively examines nanocarrier-mediated drug delivery systems as a transformative platform for diabetic wound management, integrating herbal, synthetic, semi-synthetic and gene-based therapeutics across preclinical and clinical landscapes. Emphasis is placed on the molecular pathophysiology of diabetic wounds and how advanced nanocarrier platforms enable spatiotemporal control, enhanced bioavailability, and pathway-specific modulation of inflammatory, angiogenic, antimicrobial, and regenerative processes. Material-driven functionalities, including stimuli-responsive release and multifunctional hybrid systems are critically discussed in relation to disorder-specific wound phenotypes. Furthermore, the review evaluates current preclinical models, translational barriers and emerging clinical trends, highlighting the importance of patient stratification and precision wound nanomedicine. Collectively, this work positions nanocarrier-based therapeutics as a promising and adaptable approach capable of addressing the biological heterogeneity of diabetic wounds and advancing toward clinically meaningful outcomes. Keywords: angiogenesis; diabetic wounds; gene therapy; herbal therapeutics; nanocarriers; wound healing
- Open Access
- 15 December 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (12) , 193-216
A Systematic Review on Hepatoprotective Medicinal Plants, Their Bioactive Compounds, and Pharmaceutical Formulations
The liver is a vital organ responsible for metabolism, detoxification, and maintaining physiological balance, yet it is highly vulnerable to damage from alcohol, drugs, toxins, and infections. Conventional treatments for liver disorders often have limited efficacy and may cause additional hepatic stress, highlighting the need for safer alternatives. Medicinal plants have emerged as promising hepatoprotective agents due to their antioxidant, anti-inflammatory, antifibrotic, and antiviral properties. Herbs such as Silybum marianum, Phyllanthus niruri, Picrorhiza kurroa, Curcuma longa, Tinospora cordifolia, Glycyrrhiza glabra, Boerhaavia diffusa, and Ginkgo biloba have shown significant protective effects in experimental models.2 Popular herbal formulations like silymarin and Liv-52 are widely used for liver disorders and demonstrate beneficial outcomes in preclinical studies. In India, particularly in Chhattisgarh, these plants form an integral part of traditional medicine and exhibit promising local effectiveness. However, despite strong experimental evidence, clinical validation remains limited. To achieve global acceptance, further research focusing on standardized extracts, well-designed clinical trials, and modern dosage formulations is essential to confirm the therapeutic potential of these hepatoprotective medicinal plants. Keywords: Hepatoprotective agents, Herbal medicines, Polyherbal formulations, Liver disorders
- 15 December 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (12) , 193-216
Open AccessA Systematic Review on Hepatoprotective Medicinal Plants, Their Bioactive Compounds, and Pharmaceutical Formulations
The liver is a vital organ responsible for metabolism, detoxification, and maintaining physiological balance, yet it is highly vulnerable to damage from alcohol, drugs, toxins, and infections. Conventional treatments for liver disorders often have limited efficacy and may cause additional hepatic stress, highlighting the need for safer alternatives. Medicinal plants have emerged as promising hepatoprotective agents due to their antioxidant, anti-inflammatory, antifibrotic, and antiviral properties. Herbs such as Silybum marianum, Phyllanthus niruri, Picrorhiza kurroa, Curcuma longa, Tinospora cordifolia, Glycyrrhiza glabra, Boerhaavia diffusa, and Ginkgo biloba have shown significant protective effects in experimental models.2 Popular herbal formulations like silymarin and Liv-52 are widely used for liver disorders and demonstrate beneficial outcomes in preclinical studies. In India, particularly in Chhattisgarh, these plants form an integral part of traditional medicine and exhibit promising local effectiveness. However, despite strong experimental evidence, clinical validation remains limited. To achieve global acceptance, further research focusing on standardized extracts, well-designed clinical trials, and modern dosage formulations is essential to confirm the therapeutic potential of these hepatoprotective medicinal plants. Keywords: Hepatoprotective agents, Herbal medicines, Polyherbal formulations, Liver disorders
- Open Access
- 15 November 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (11) , 134-155
Intranasal nanoparticulate drug delivery systems for neurodegenerative disorders: an Overview
Intranasal nanoparticulate drug delivery systems have received increased attention in pharmaceutical research due to their ability to increase drug bioavailability, bypass the blood-brain barrier (BBB), and provide non-invasive, patient-friendly alternatives to drug administration, particularly for drugs intended for central nervous system (CNS) disorders. Drugs delivered via nasal route can enter the CNS via the olfactory pathway or the trigeminal nerve pathway, enabling access to deeper regions. Intranasal nanoparticulate systems have several pharmacological benefits, including increased bioavailability, a faster onset of action, higher patient compliance, and less systemic adverse effects. Intranasal nanoparticulate drug delivery has shown promise in a variety of therapeutic areas, including Alzheimer's disease, Parkinson's disease, depression, and anxiety. Intranasal vaccinations and antibacterial Nanoparticle are also utilized to treat respiratory and viral illnesses. This technique is thought to be useful in brain-targeted chemotherapeutic drugs for glioblastoma treatment. The authors of this review attempted to investigate the pharmacological features of nanoparticulate drug delivery systems, including their benefits, mechanisms, formulation methodologies, and clinical applications. Keywords: Alzheimer's disease, Drug delivery, Nanoparticle, Nasal route, Neuro inflammation, Parkinson’s disease,
- 15 November 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (11) , 134-155
Open AccessIntranasal nanoparticulate drug delivery systems for neurodegenerative disorders: an Overview
Intranasal nanoparticulate drug delivery systems have received increased attention in pharmaceutical research due to their ability to increase drug bioavailability, bypass the blood-brain barrier (BBB), and provide non-invasive, patient-friendly alternatives to drug administration, particularly for drugs intended for central nervous system (CNS) disorders. Drugs delivered via nasal route can enter the CNS via the olfactory pathway or the trigeminal nerve pathway, enabling access to deeper regions. Intranasal nanoparticulate systems have several pharmacological benefits, including increased bioavailability, a faster onset of action, higher patient compliance, and less systemic adverse effects. Intranasal nanoparticulate drug delivery has shown promise in a variety of therapeutic areas, including Alzheimer's disease, Parkinson's disease, depression, and anxiety. Intranasal vaccinations and antibacterial Nanoparticle are also utilized to treat respiratory and viral illnesses. This technique is thought to be useful in brain-targeted chemotherapeutic drugs for glioblastoma treatment. The authors of this review attempted to investigate the pharmacological features of nanoparticulate drug delivery systems, including their benefits, mechanisms, formulation methodologies, and clinical applications. Keywords: Alzheimer's disease, Drug delivery, Nanoparticle, Nasal route, Neuro inflammation, Parkinson’s disease,